• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Dry Eye Disease 
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for Dry Eye disease trials.

DOWNLOAD BROCHURE GET IN TOUCH

Effective solutions for advancing Dry Eye Disease research

Dry eye disease (DED) is among the most common eye disorders. Patients may additionally suffer from underlying systemic diseases, which can further complicate DED studies. Since DED symptoms can cause a long-term decline in patients’ health-related quality of life, it’s important that researchers collect patient-reported outcomes (PROs) that can serve as primary and secondary endpoint data. Our in-house experts and Signant SmartSignals solution suite can help.

Our in-house experts understand the characteristics of the necessary disease-specific questionnaires, including but not limited to:

  • National Eye Institute Visual Function Questionnaire (NEI VFQ-25)
  • Ocular Surface Disease Index (OSDI)
  • Impact of Dry Eye in Everyday Life (IDEEL)
  • Dry Eye-Related Quality of Life Score (DEQS)

Why Signant Health

  • Improve Endpoint Data Quality
  • Keep Patients Engaged
  • Manage Supplies Efficiently
  • Accelerate Patient Enrollment
  • Improve Endpoint Data Quality

    Improve Endpoint Data Quality

    Signant’s eCOA solution provides real-time insights into the patients’ symptoms, satisfaction with the treatment, as well as the treatment’s effect on their quality of life. Complete with a library of validated questionnaires, our eCOA solution accelerates study startup times.
     

  • Keep Patients Engaged

    Keep Patients Engaged

    Patient Engagement puts visit schedules and information directly at the patients’ fingertips. Conveniently located on the same platform as our eCOA solution, the engagement tool provides interactive multimedia to educate patients on their condition and the study. It also features built-in reminders to drive completion adherence.
     

  • Manage Supplies Efficiently

    Manage Supplies Efficiently

     Choose our Randomization & Trial Supply Management (RTSM) solution to efficiently handle the logistical complexities of randomization. You’ll be able to successfully deliver medication on time and with an optimized shelf life. The digital tool also pools the supplies across studies to reduce waste and overage expense in the process.
     

  • Accelerate Patient Enrollment

    Accelerate Patient Enrollment

     Our Telemedicine solution offers a secure and compliant virtual platform for multi-person meetings. Designed to reduce the number of in-person visits required and the associated burdens, Telemedicine can be particularly helpful in replacing in-person consultations that do not require objective on-site assessments.

Comprehensive Dry Eye Disease experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our Dry Eye Disease trial resources
SOLUTION BROCHURE

Dry Eye Disease Trial Solutions Overview


GET INSIGHTS
VIDEO

Dry Eye Disease Trial Solutions


WATCH [2 MIN]
SOLUTION

Rater Training & Qualification



LEARN MORE

eClinical solutions for Dry Eye Disease trials

Ready to learn more?

Discover how Signant can support your current or upcoming dry eye trials. 

DOWNLOAD BROCHURE GET STARTED